Quick answer: Ambien (zolpidem) and zopiclone are both “Z-drugs,” sleep medicines that act on the same GABA system in the brain, but they are not the same drug and they are not sold in the same places. Zolpidem is available in the United States and in many other countries. Zopiclone is widely prescribed in the UK, Canada, Europe, Australia and elsewhere, but it was never approved by the U.S. FDA. In the United States, the closest equivalent is eszopiclone (Lunesta), the active half of the zopiclone molecule. Zolpidem generally works faster and leaves the body sooner, while zopiclone lasts longer and often causes a bitter or metallic taste. Both carry real risks, including next-day impairment, memory problems, and complex sleep behaviors.
If you have moved between countries, read a European leaflet, or heard a friend abroad mention a sleeping pill you have never seen at your pharmacy, you may have wondered whether zopiclone is just “European Ambien.” The short answer is that they are close cousins rather than twins. This guide maps out how the two compare in chemistry, dosing, effects, safety, and, importantly, legal status. It is educational and does not replace advice from a clinician who knows your history.
Meet the Z-Drug Family
The term “Z-drugs” refers to a group of non-benzodiazepine sleep medicines whose generic names happen to start with the letter Z (or sound like they do). They were developed as alternatives to benzodiazepines, with a more selective action on GABA-A receptors. Despite that, they work by a similar overall mechanism and share many of the same safety concerns.
- Zolpidem (Ambien, Ambien CR, Edluar, Intermezzo, and others; Stilnox and other brands in some countries)
- Zopiclone (Imovane, Zimovane, and others in countries where it is marketed)
- Eszopiclone (Lunesta), the single active S-enantiomer of zopiclone
- Zaleplon (Sonata), a short-acting Z-drug
That list sets up a point that confuses many readers. Zopiclone is a “racemic” mixture, meaning it contains two mirror-image forms of the same molecule. Only one of them, the S-form, is thought to be mainly responsible for the sleep-promoting effect. Eszopiclone is that S-form isolated by itself. So zopiclone and eszopiclone are closely related, and eszopiclone is in effect the version that reached the U.S. market.
A Short History: How One Molecule Ended Up With Two Passports
Zopiclone was introduced in Europe in the 1980s and became one of the most widely prescribed sleeping pills there. A U.S. company later isolated the S-enantiomer, developed it as eszopiclone, and received FDA approval in December 2004 under the brand name Lunesta. The Drug Enforcement Administration placed zopiclone, including its isomers, into Schedule IV of the Controlled Substances Act in 2005, a few months after Lunesta’s approval.
The result is that zopiclone is a controlled substance in the United States on paper, but it is not commercially marketed there, and eszopiclone fills the role. In other countries the situation is reversed: zopiclone is the established product, and eszopiclone has been less common or only recently introduced in some markets. Regulatory approvals continue to change, so check local information if the exact status matters to you.
Regulatory Passport Check
The table below summarizes the general picture. Laws and approvals change, so treat it as an orientation rather than a legal guide.
| Region | Zolpidem (Ambien and generics) | Zopiclone | Eszopiclone (Lunesta) |
|---|---|---|---|
| United States | FDA-approved; Schedule IV | Not FDA-approved or commercially marketed; listed as a Schedule IV substance | FDA-approved (2004); Schedule IV |
| United Kingdom | Available; prescription-only | Widely prescribed; a Class C controlled drug | Historically not widely available; check current licensing |
| Canada | Available by prescription | Long established (Imovane and generics); controlled | Check current status; less established than zopiclone |
| European Union | Available in many countries | Widely available | Limited |
| Australia | Available; prescription-only | Available; prescription-only | Check current status |
One practical note: because zopiclone is not an FDA-approved product, buying it from an overseas website for use in the United States is risky and may be illegal without a valid prescription. Counterfeit sleeping pills are a real hazard, and illicit tablets have been found to contain other drugs. If you need a sleep medicine, work with a prescriber in your own country.
Chemistry and Action: Similar Target, Different Footprints
Both zolpidem and zopiclone enhance the effect of GABA at GABA-A receptors, which slows brain activity and promotes sleep. The details differ:
- Zolpidem is relatively selective for a particular receptor subtype associated with sedation, which is why it has less effect on anxiety and muscle relaxation than classic benzodiazepines.
- Zopiclone acts more broadly on several receptor subtypes, so it can have somewhat more muscle-relaxant and anti-anxiety effects. It is structurally unrelated to benzodiazepines, but it acts at a nearby site on the receptor.
These differences are subtle, and clinical studies have not shown that one is clearly superior for every person. What differs more obviously is how long each drug stays in the body.
Speed, Duration, and Next-Day Effects
How Fast They Work
Immediate-release zolpidem is known for quick onset, which is why labeling tells you to take it right as you get into bed. Zopiclone also acts relatively quickly, usually within an hour or so, and is typically taken just before bed as well.
How Long They Last
Zolpidem has a short half-life, on the order of a couple of hours in many adults, and longer in women, older adults, and people with liver problems. Zopiclone’s half-life is longer, usually quoted at about five hours in younger adults and longer in people over 65. Eszopiclone’s half-life is roughly six hours. A longer half-life can mean more sleep maintenance for some people, but it can also mean more drug on board in the morning.
The Morning After
This is one of the practical differences that matters. Regulators in several countries have warned about next-day impairment with both drugs. The U.S. FDA reduced recommended zolpidem doses in 2013 after finding that blood levels the next morning could impair driving, especially in women. Health regulators in other countries have also issued dosing guidance for zopiclone because impairment could last into the following day. Regardless of the drug, the FDA’s broader reminder holds: all insomnia medicines can impair driving and alertness the morning after, even if you feel awake. See our guide to Ambien next-day drowsiness and driving.
Comparison Table: Zolpidem, Zopiclone, and Eszopiclone
| Feature | Zolpidem (Ambien) | Zopiclone | Eszopiclone (Lunesta) |
|---|---|---|---|
| Molecule | Imidazopyridine | Cyclopyrrolone, racemic mixture | Single S-enantiomer of zopiclone |
| Typical tablet strengths | 5 mg and 10 mg (immediate-release); 6.25 mg and 12.5 mg (extended-release) | 3.75 mg and 7.5 mg in many countries | 1 mg, 2 mg, and 3 mg |
| Typical onset | Fast | Fast to moderate | Moderate |
| Approximate half-life | Short (roughly 2 to 3 hours in many adults; longer in some groups) | About 5 hours; longer in older adults | About 6 hours; longer in older adults |
| Common distinctive side effect | Memory gaps, complex sleep behaviors | Bitter or metallic taste, dry mouth, next-day drowsiness | Unpleasant taste is common, plus drowsiness |
| Boxed warning for complex sleep behaviors (U.S.) | Yes | Not applicable (not U.S.-marketed) | Yes |
| Controlled status | Schedule IV (U.S.) | Schedule IV (U.S.), Class C (UK) | Schedule IV (U.S.) |
Side Effects: What Overlaps and What Doesn’t
Shared by Both
- Drowsiness, dizziness, and headache
- Next-day impairment, including slowed reaction time and trouble concentrating
- Memory problems and amnesia after dosing
- Complex sleep behaviors such as sleepwalking, sleep-eating, and sleep-driving
- Mood changes, including worsening depression in some people
- Rebound insomnia after stopping, and tolerance or dependence with prolonged nightly use
More Characteristic of Zopiclone and Eszopiclone
- A bitter or metallic taste. This is the classic complaint and can linger through the night and into the morning.
- Dry mouth.
- Morning grogginess related to the longer half-life.
More Characteristic of Zolpidem
- Prominent memory gaps when people stay awake after dosing.
- Dose-related next-day impairment, which led to the FDA’s sex-specific dosing. See why women get a lower Ambien dose.
The Safety Story That Applies to the Whole Family
In April 2019, the FDA required a boxed warning on zolpidem, eszopiclone, and zaleplon after reviewing 66 cases over roughly 26 years of serious injuries linked to complex sleep behaviors, including 20 deaths. Most of the reported cases involved zolpidem, which is consistent with how widely it is prescribed. The agency also added a contraindication for people who have previously experienced a complex sleep behavior with one of these medicines. The warning applies to the Z-drug class in the U.S., and it is wise to consider it relevant for zopiclone too, because the same mechanism is at work. Read more in our article on Ambien and memory loss.
Several other cautions apply to any Z-drug:
- Alcohol. It increases sedation and the risk of complex sleep behaviors. Avoid it.
- Other sedatives. Opioids, benzodiazepines, sedating antihistamines, and some antidepressants can add to drowsiness. See why combining Ambien and Benadryl is risky.
- Older adults. Lower doses are recommended, and falls and confusion are greater concerns.
- Liver disease. Drug levels can run higher.
- Sleep apnea and lung disease. Sedatives can worsen breathing during sleep.
- Pregnancy and breastfeeding. Discuss with a clinician. See Ambien in pregnancy.
Drug Interactions Worth Knowing
Zolpidem, zopiclone, and eszopiclone are processed at least partly by the liver enzyme CYP3A4, so certain medicines can raise or lower their levels. Examples include some antifungals and macrolide antibiotics (such as erythromycin), which can increase exposure, and some anti-seizure medicines and rifampin, which can reduce it. The practical advice is the same for all three: bring your full medicine list, including supplements, to your prescriber or pharmacist. St. John’s wort and other herbal products can also change drug metabolism.
Dependence, Tolerance, and Stopping
All three drugs can cause physical and psychological dependence, especially with long-term nightly use or higher doses. Stopping suddenly can lead to rebound insomnia, anxiety, irritability, and in some cases more significant withdrawal symptoms. In the UK, zopiclone was reclassified as a Class C controlled drug in 2014 after concerns about misuse and diversion. Health authorities in several countries have also urged short-term use, often framed in weeks rather than months.
If you have used a Z-drug nightly for a long time, don’t stop abruptly. A gradual taper under clinician supervision is the standard approach, often combined with cognitive behavioral therapy for insomnia (CBT-I) to rebuild natural sleep.
Can You Swap One for the Other?
It’s tempting to treat milligrams as interchangeable, but they aren’t. A 7.5 mg zopiclone tablet is not “equal” to a 10 mg zolpidem tablet in a way you can calculate at home. Differences in half-life, receptor activity, sex, age, and liver function all affect response. Moving between countries or switching products is a decision for a prescriber, who may start at a lower dose and adjust.
If you are traveling or relocating and take one of these medicines, a few practical steps help:
- Carry your medicine in its original labeled container with a copy of your prescription.
- Check the destination country’s rules before you go. Controlled-substance regulations differ widely, and some countries restrict or ban products that are legal at home.
- Ask your prescriber for a plan for when your supply runs out, including whether a local equivalent exists and who will supervise the switch.
- Avoid buying from online sellers without a prescription. Counterfeit and contaminated tablets are a documented risk.
How the U.S. Alternatives Stack Up
If you are in the United States and wondering what to ask about instead of zopiclone, here is a quick orientation.
- Eszopiclone (Lunesta). The closest equivalent. Compare it in our guide to Ambien vs. Lunesta.
- Zaleplon (Sonata). A short-acting option designed for trouble falling asleep. See Sonata vs. Ambien, and our explainer on how long Sonata stays in your system.
- Ramelteon (Rozerem). Works on melatonin receptors rather than GABA. See Rozerem vs. Ambien.
- Orexin receptor antagonists. A different class that blocks the wake signal. See Ambien vs. Belsomra.
- Sedating antidepressants. Sometimes used off-label. See Ambien vs. trazodone.
- CBT-I. The primary treatment recommended for chronic insomnia, with no drug interactions.
Which One Is “Better”? An Honest Answer
No head-to-head comparison establishes that zopiclone or zolpidem is clearly better overall. Reviews of these drugs usually find similar benefits on falling asleep and similar safety concerns, with differences at the margins: zolpidem tends to be quicker and shorter, while zopiclone tends to last longer and leave a taste. For many people the deciding factors are practical: which one is available where they live, which is covered by insurance or a national health system, which fits their sleep pattern, and which they tolerate.
A reasonable way to approach the question with your clinician is to describe your pattern, whether it’s difficulty falling asleep, waking in the night, or both, and your morning commitments. Then ask which option gives you the best chance of benefit with the lowest dose, for the shortest time.
Questions to Bring to Your Appointment
- Is a Z-drug the right choice for my insomnia, or should we start with CBT-I?
- If I use one, what is the lowest effective dose for my age and sex?
- How long should I plan to use it, and what is the plan for stopping?
- Do any of my other medicines or supplements interact with it?
- When is it safe to drive the morning after?
- What should I do if I notice memory gaps or unusual nighttime behavior?
- If I’m moving or traveling, how do I handle my prescription?
Six Myths About Zolpidem and Zopiclone
Myth 1: “Zopiclone is just a European brand name for Ambien.”
They are different drugs. Ambien is zolpidem, a different molecule with its own strengths, timing, and side effects. Zopiclone belongs to a separate chemical family, even though the two act on the same receptor system.
Myth 2: “If a drug is sold in Europe for decades, it must be safer.”
Long use gives regulators plenty of safety data, which is useful, but it has also revealed problems such as dependence, withdrawal, and next-day impairment. Several countries have tightened rules on zopiclone over the years, including classifying it as a controlled drug in the UK.
Myth 3: “A taste problem means it’s not working properly.”
The bitter or metallic taste is a known side effect caused by the drug appearing in saliva. It doesn’t tell you anything about whether the medicine is effective or whether you are taking it correctly, though if it bothers you, tell your prescriber.
Myth 4: “Since eszopiclone is purified, it must be better than zopiclone.”
Isolating the active form sounds like an improvement, but reviews of single-enantiomer versions of older drugs often find little difference in real-world outcomes. A drug information service in British Columbia reviewed this exact question in 2021 and concluded that it was unclear whether eszopiclone differs meaningfully from zopiclone for efficacy or safety, though it costs more in that setting.
Myth 5: “The Z-drugs don’t cause dependence like benzodiazepines.”
They were designed to be more selective, and many clinicians once hoped they would carry less risk. Experience has shown that tolerance, dependence, and withdrawal can occur, especially with long-term nightly use. That is why they are controlled drugs and why guidelines emphasize short courses.
Myth 6: “I can take a bit more because I’m used to it.”
Tolerance to sleep-promoting effects can develop, but that doesn’t mean your risks have shrunk. Higher doses increase the chance of next-day impairment, memory gaps, and complex sleep behaviors. If your usual dose has stopped working, that’s a reason to see your prescriber, not to self-adjust.
Three Real-World Scenarios
These composite examples illustrate how the comparison plays out in daily life. They are not medical advice.
Scenario 1: The Relocation
A professional moves from the UK to the United States with a supply of zopiclone. She finds that her new pharmacy doesn’t stock it. Her U.S. prescriber, after reviewing her history, discusses eszopiclone, other medicine options, and CBT-I. Rather than converting milligrams herself, she begins at a lower dose, tracks her mornings, and has a follow-up appointment scheduled. This is the safest pattern: a new prescriber, a fresh assessment, and a plan for review.
Scenario 2: The Early Commuter
A man in Canada takes zopiclone at midnight and leaves for a long drive at 6 a.m. He feels fine, but the drug’s longer half-life means more medicine may still be in his system than he realizes. After a near miss on the highway, he talks with his doctor, who lowers his dose and advises him to skip the pill on nights before early drives. Everyone’s impairment threshold is different, so the lesson is to treat the morning after as a risk period, not as a matter of how awake you feel.
Scenario 3: The Online Shortcut
A traveler in the United States hears about zopiclone and orders it from an overseas website without a prescription. The tablets look right, but nobody can verify what they actually contain. Counterfeit and contaminated sleep medicines are a known hazard, and a pill that looks like a sleep aid can contain much more of a sedating drug than expected. A far safer step would be to ask a U.S. prescriber about FDA-approved options.
Frequently Asked Questions
Is zopiclone the same as Ambien?
No. Both are Z-drugs that act on GABA-A receptors, but they are different molecules with different strengths, half-lives, and side-effect patterns. Zopiclone is a longer-acting, racemic drug often associated with a bitter taste. Ambien is zolpidem, which is generally shorter-acting.
Is zopiclone available in the United States?
Zopiclone is not FDA-approved or commercially marketed in the United States. Eszopiclone (Lunesta), the active S-enantiomer, is the U.S.-approved counterpart.
Which one is stronger?
“Stronger” is not very meaningful across different drugs and doses. They have different potencies per milligram and different durations. What matters is the dose that works for you with the fewest effects the next day.
Does zopiclone cause more next-day drowsiness than Ambien?
It can, because it stays in the body longer. Individual responses vary, and both drugs can impair driving the morning after, so use caution with either.
Why does zopiclone leave a metallic taste?
The drug and its metabolites are secreted in saliva, which causes a bitter or metallic taste for many users. It is usually harmless but can be unpleasant, and it is also common with eszopiclone.
Can I take either with alcohol?
It is not recommended. Alcohol increases sedation, impairment, and the risk of complex sleep behaviors with all Z-drugs.
Are Z-drugs addictive?
They have recognized potential for dependence and are controlled substances in many countries. The risk is generally higher with long-term nightly use and with a history of substance misuse. Discuss your personal risk with your prescriber.
What should I do if I have a sleepwalking episode?
The FDA’s advice is to stop the medicine and contact a health care professional right away. Do not wait for your next routine appointment.
Key Takeaways
- Ambien (zolpidem) and zopiclone are related Z-drugs, but they are different molecules with different half-lives and side-effect profiles.
- Zopiclone is widely used outside the United States but was never FDA-approved. Eszopiclone (Lunesta), its active S-form, is the U.S. equivalent.
- Zolpidem is usually quicker and shorter-acting. Zopiclone tends to last longer and commonly causes a bitter or metallic taste.
- All of them carry risks of next-day impairment, memory problems, and complex sleep behaviors, and the FDA’s boxed warning covers zolpidem and eszopiclone.
- Don’t convert doses yourself, don’t buy from unverified online sellers, and don’t stop long-term use suddenly.
- CBT-I remains the recommended foundation for chronic insomnia.
Sources and Further Reading
- U.S. Food and Drug Administration: Boxed Warning for complex sleep behaviors with certain insomnia medicines
- U.S. Food and Drug Administration: Drug Safety Communication on zolpidem dosing and next-day driving
- NHS (UK): Zopiclone
- British Columbia Provincial Academic Detailing Service: How does eszopiclone (Lunesta) differ from zopiclone?
Medical disclaimer: This content is for general education only and does not replace professional medical advice, diagnosis, or treatment. Talk with your doctor or pharmacist before starting, changing, or stopping any medicine. If you or someone else is in an emergency, call your local emergency number right away.
